ArticleVaccines2023

Intranasal Single-Replication Influenza Vector Induces Cross-Reactive Serum and Mucosal Antibodies against SARS-CoV-2 Variants.

Michael J Moser et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.